SCHEMBL25992738

SCHEMBL25992738

Cc1cccc(-c2cn(Cc3ccc(-c4nnc(C(F)F)o4)cc3F)nn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEK Q02763 4/20 0.47
▸ KDR P35968 4/20 0.47
▸ EPHB4 P54760 1/20 0.47
▸ HDAC1 Q13547 10/20 0.43
▸ HDAC6 Q9UBN7 3/20 0.42
▸ ROCK2 O75116 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ PAK4 O96013 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ RPS6KB1 P23443 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ PRKAA1 Q13131 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25992736 0.91 HDAC6 (0.43) HDAC1HDAC6
SCHEMBL25351646 0.90 DPP4 (0.48) TEKKDREPHB4HDAC1HDAC6
SCHEMBL30410054 0.89 HDAC1 (0.42) HDAC1HDAC6ROCK2GSK3BPAK4
SCHEMBL24215788 0.89 HDAC1 (0.42) HDAC1HDAC6ROCK2GSK3BPAK4
SCHEMBL24215834 0.89 HDAC1 (0.48) HDAC1HDAC6ROCK2GSK3BPAK4
SCHEMBL30409440 0.89 HDAC1 (0.48) HDAC1HDAC6ROCK2GSK3BPAK4
SCHEMBL24216081 0.89 TEK (0.47) TEKKDREPHB4HDAC1HDAC6
SCHEMBL30409885 0.89 TEK (0.47) TEKKDREPHB4HDAC1HDAC6
SCHEMBL25350410 0.88 HDAC6 (0.45) HDAC1HDAC6ROCK2GSK3BPAK4
SCHEMBL24216445 0.88 HDAC1 (0.47) HDAC1HDAC6ROCK2GSK3BPAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 TEK 3885/4885KDR 4706/4885EPHB4 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback